Valeant Pharmaceuticals International Inc received a takeover approach this spring from Takeda Pharmaceutical Co and investment firm TPG, which it rejected, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
Specialty drugmaker Valeant has been struggling to revive itself after its business model and drug pricing practices came under scrutiny, and it recently brought in a new CEO, Joseph Papa. The Takeda-TPG approach — which did not include a firm price — was made before Papa’s appointment, and there are no talks under way currently, the Journal reported.
Papa on Monday said at the UBS Global Healthcare Conference that Valeant has a “very good pipeline” of new drugs that has not been fully appreciated.
The board is giving Papa time to set a new course for the Laval, Quebec-based drugmaker, the Journal said.
Representatives for three firms declined to comment.
Valeant bought Salix Pharmaceuticals Ltd last year, gaining access to a portfolio of gastrointestinal treatments, a disease area Takeda is focusing on.
Osaka-based Takeda is Japan’s largest pharmaceutical company, and CEO Christophe Weber has repeatedly stated his ambitions to make the company a global leader in oncology and gastrointestinal treatments and to gain control of new drugs the company can develop to sell worldwide.
The Japanese drugmaker spent more than US$21 billion on its two biggest acquisitions, purchasing Millennium Pharmaceuticals Inc to expand in cancer therapies in 2008 and Zurich-based Nycomed in 2011 to grow in emerging markets.
A deal with Valeant would have given Takeda access to Xifaxan, a potential blockbuster drug for irritable bowel syndrome.
TPG, whose main offices are in San Francisco and Fort Worth, Texas, has more than US$70 billion under management and has invested in all sectors of healthcare, including hospitals, biotechnology firms and insurers.
On Tuesday, US President Donald Trump weighed in on a pressing national issue: The rebranding of a restaurant chain. Last week, Cracker Barrel, a Tennessee company whose nationwide locations lean heavily on a cozy, old-timey aesthetic — “rocking chairs on the porch, a warm fire in the hearth, peg games on the table” — announced it was updating its logo. Uncle Herschel, the man who once appeared next to the letters with a barrel, was gone. It sparked ire on the right, with Donald Trump Jr leading a charge against the rebranding: “WTF is wrong with Cracker Barrel?!” Later, Trump Sr weighed
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) secured a record 70.2 percent share of the global foundry business in the second quarter, up from 67.6 percent the previous quarter, and continued widening its lead over second-placed Samsung Electronics Co, TrendForce Corp (集邦科技) said on Monday. TSMC posted US$30.24 billion in sales in the April-to-June period, up 18.5 percent from the previous quarter, driven by major smartphone customers entering their ramp-up cycle and robust demand for artificial intelligence chips, laptops and PCs, which boosted wafer shipments and average selling prices, TrendForce said in a report. Samsung’s sales also grew in the second quarter, up
HEADWINDS: Upfront investment is unavoidable in the merger, but cost savings would materialize over time, TS Financial Holding Co president Welch Lin said TS Financial Holding Co (台新新光金控) said it would take about two years before the benefits of its merger with Shin Kong Financial Holding Co (新光金控) become evident, as the group prioritizes the consolidation of its major subsidiaries. “The group’s priority is to complete the consolidation of different subsidiaries,” Welch Lin (林維俊), president of the nation’s fourth-largest financial conglomerate by assets, told reporters during its first earnings briefing since the merger took effect on July 24. The asset management units are scheduled to merge in November, followed by life insurance in January next year and securities operations in April, Lin said. Banking integration,
LOOPHOLES: The move is to end a break that was aiding foreign producers without any similar benefit for US manufacturers, the US Department of Commerce said US President Donald Trump’s administration would make it harder for Samsung Electronics Co and SK Hynix Inc to ship critical equipment to their chipmaking operations in China, dealing a potential blow to the companies’ production in the world’s largest semiconductor market. The US Department of Commerce in a notice published on Friday said that it was revoking waivers for Samsung and SK Hynix to use US technologies in their Chinese operations. The companies had been operating in China under regulations that allow them to import chipmaking equipment without applying for a new license each time. The move would revise what is known
RSS